Lipodystrophy in pediatric HIV

Indian Journal of Pediatrics

Volumn 75, Issue 4, 2008, Pages 351-354

  Desai, Ninad ^a,c   Mullen, Patricia ^a   Mathur, Mudit ^b  

^a SUNY Downstate Medical Center   (United States)

^b LOMA LINDA UNIVERSITY CHILDREN S HOSPITAL   (United States)

^c University Hospital of Brooklyn   (United States)

Author keywords

BMI; Lipodystrophy; Perinatal HIV

Indexed keywords

PROTEINASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ARTICLE; BODY FAT; BODY HEIGHT; BODY MASS; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLIPIDEMIA; IMPEDANCE; LIPID STORAGE; LIPODYSTROPHY; LONG TERM CARE; MALE; MORBIDITY; OBESITY; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; WASTING SYNDROME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; AGE DISTRIBUTION; ANALYSIS OF VARIANCE; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BODY MASS INDEX; BODY WEIGHT; CHILD; ELECTRIC IMPEDANCE; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; INCIDENCE; LIPODYSTROPHY; MALE; PROBABILITY; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEX DISTRIBUTION;

EID: 44049092911     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12098-008-0037-2     Document Type: Article

References (10)

1. Barbaro G. Metabolic and cardiovascular complications of highly active antiretroviral therapy for HIV infection. Current HIV Research 2006; 1: 79-85.
2. Carr A. HIV-protease inhibitor related Lipodystrophy syndrome. Clinical Infectious Diseases; 30(Supplement 2). 2000; S135-S142.
3. www.cdc.gov : CDC advance data no. 314; December 4, 2000
4. Pietrobelli A, Faith MS, Allison DB, Gallagher D, Chiumello G, Heymsfields B. Body mass index as a measure of adiposity among children and adolescents: A validation study. J Pediatr 1998; 132: 204-210.
5. Lazarus R, Baur L, Webb K, Blyth F. BMI in screening for adiposity in children and adolescents: systematic evaluation using receiver operating curves. Amer J Clin Nutr 1996; 63: 500-506.
6. Sluys T, Vander Ende ME, Swart CR, VandenBerg JW, Wilson, JH. Body composition in patients with acquired immunodeficiency syndrome: a validation study of bioelectric impedance analysis. J Parenteral Enteral Nutrition 1993; 17: 404-406.
7. Spencer CE, Lingard JM, Bermingham MA. Comparison of a footpad analyzer with a tetrapolar model for the determination of percent body fat in young men. J Science Med Sport/Sports Med Australia 2003; 6: 455-460.
8. Lasalle S, Cervera P, Hofman V, Mari M, Dellamonica P, Hofman P. Antiretroviral treatments related lipodystrophy syndrome: Clinico-pathological findings. Annales de Pathologie 2005; 25: 309-317.
9. Power R, Tate HL, McGill SM, Taylor C. A qualitative study of the psychosocial implications of Lipodystrophy syndrome on HIV positive individuals. Sexual Transmit Infect 2003; 79: 137-141.
10. Saint-Marc T, Partisani M, Poizot-Martin I et al. Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study. AIDS 2000; 14: 37-49.